Solventum Co. (NYSE:SOLV) Shares Sold by Biltmore Family Office LLC

Biltmore Family Office LLC reduced its position in Solventum Co. (NYSE:SOLV) by 8.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,086 shares of the company’s stock after selling 299 shares during the quarter. Biltmore Family Office LLC’s holdings in Solventum were worth $204,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in SOLV. Modus Advisors LLC acquired a new stake in Solventum in the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC purchased a new position in shares of Solventum during the 4th quarter valued at approximately $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the fourth quarter worth approximately $32,000. Synergy Asset Management LLC bought a new position in Solventum during the 4th quarter valued at $35,000. Finally, Spire Wealth Management acquired a new position in Solventum during the 4th quarter worth $37,000.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on SOLV shares. Mizuho upped their target price on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. Bank of America upped their price target on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 26th. Piper Sandler increased their target price on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, February 28th. The Goldman Sachs Group lifted their price target on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday, March 3rd. Finally, Wells Fargo & Company raised their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Solventum currently has an average rating of “Hold” and an average target price of $79.86.

Solventum Trading Up 0.3 %

Shares of NYSE:SOLV opened at $76.54 on Thursday. The firm has a market cap of $13.24 billion and a P/E ratio of 27.83. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $85.92. The company has a 50 day moving average of $75.66 and a 200-day moving average of $72.00.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.